We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boston Scientific said it has not had any settlement discussions with Israeli
stent maker Medinol, the company's former partner, contrary to an Israeli news
report.
HeartSine Technologies is initiating a worldwide recall of some samaritan automatic
external defibrillators (AEDs) -- specifically, models SAM-001, SAM-002 and SAM-003
with certain serial numbers within the range of 1270-2324 -- because they may
shut down before delivering a shock, which could result in the delayed treatment
or death of a viable patient.
MIV Therapeutics (MIVT), a developer of next-generation biocompatible coatings
and drug delivery technologies, has executed an agreement to acquire SagaX Medical
Technologies, a company developing a range of proprietary solutions that decrease
the likelihood of strokes and other complications from cardiac procedures as
well as naturally occurring cardioembolic strokes.
Prescription skin medication maker Medicis Pharmaceutical has agreed to purchase
Inamed, a maker of breast implants and obesity treatments, for roughly $2.8
billion in cash and stock.
Kensey Nash previously announced on Feb. 7 that the company had submitted a
response to the FDA comments focused on labeling and clarification of previously
submitted data in its submission for 510(k) clearance of the triActiv System.
Baxa announced the addition of four specialty administration sets to the MicroFuse
Syringe Infusion System line. These new sets incorporate a T-site for the convenient
administration of coronary vasodilators during myocardial perfusion imaging.